An international team of researchers led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the ...

Two open-access reviews by a renowned neonatal immunologist have highlighted the uniqueness of the developing infant immune ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

A deep learning artificial intelligence model developed at Washington State University can identify pathology, or signs of ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

A paper shows how partnering with the community can lead to more inclusive health care, especially for individuals with ...

Many of England's pharmacy technicians are forced to endure low pay, poor job satisfaction, bullying, lack of support and ...

The researchers found that fit individuals shared similar risks of death and cardiovascular disease over the course of the ...

Most cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

Could you imagine having a driving lesson in your 50s or 60s, even though you've been driving since your late teens? The idea ...